Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul? Source: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-june-29-to-july-5-2026 Scope: Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop Family: Ranking Top 10 Observed: Jun 29 – Jul 5, 2026 (2026-06-29/2026-07-05) Published: July 7, 2026 Method — How readings are scoped: https://theobservatory.io/method#standards Method — Run metadata: https://theobservatory.io/method/panel#run-metadata Method — Source protocol: https://theobservatory.io/method#source-protocol Method — Corrections and right of reply: https://theobservatory.io/method#corrections Public table: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-june-29-to-july-5-2026/data.csv Citation text: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-june-29-to-july-5-2026/citation.txt Reuse terms: https://theobservatory.io/terms seouldermatologyclinic.com holds the highest AI opening share on this market across the 6-run window from June 29 – July 5, 2026, at 16.19%. Key facts: • seouldermatologyclinic.com: 16% AI opening share · opening in 6/6 runs • us-uk.bookimed.com: 12% AI opening share · opening in 6/6 runs • jivaka.kr: 8% AI opening share · opening in 6/6 runs Published table — AIO opening control — top 10 (Jun 29 – Jul 5, 2026 · 80 queries per run · 6 comparable runs): Rank · Actor · AIO opening control 1. seouldermatologyclinic.com — 16.19% AI opening share · opening in 6/6 runs — #1 2. us-uk.bookimed.com — 12.38% AI opening share · opening in 6/6 runs — #2 3. jivaka.kr — 8.10% AI opening share · opening in 6/6 runs — #3 4. instagram.com — 7.14% AI opening share · opening in 5/6 runs — #4 5. youtube.com — 7.14% AI opening share · opening in 5/6 runs — #5 6. hongdaebeautyclinic.com — 6.67% AI opening share · opening in 5/6 runs — #6 7. gangnamwomenshealth.com — 6.19% AI opening share · opening in 6/6 runs — #7 8. reddit.com — 6.19% AI opening share · opening in 5/6 runs — #8 9. seoulskinclinicforforeigners.com — 5.24% AI opening share · opening in 4/6 runs — #9 10. forenaclinic.com — 4.76% AI opening share · opening in 5/6 runs — #10 Reading basis: This card observes the AI Overview opening-control rail for Luxury Medical Aesthetic Clinics Seoul in South Korea on Google desktop across 6 comparable scheduled runs in the observation period from June 29 – July 5, 2026. The top-10 panel was derived from 80 observed queries. The primary metric is AI opening share on this market, aggregated as the sum of each actor's opening values across all comparable runs in the period with one single period-wide denominator. AI Overview opening-control evidence was available on 6 of 6 runs in the window. Limitations and non-claims: — Observes the observed AI answer surface only; within a defined scope and window. — A period aggregate (6 comparable runs) — not a claim about bookings, revenue, or market share. — Scoped to Luxury Medical Aesthetic Clinics Seoul Seoul, July 2026; not generalisable beyond this market and window. — The Observatory · Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop · Jun 29 – Jul 5, 2026 Based on governed AAI Kernel evidence. Capture identifier: pr_1791395204559_tw3m5r. Cite freely with attribution. Published by The Observatory. Source footnote: Sourced from a published AAI MIB card. The Observatory publishes this card’s public findings; values are as observed on the search surface, not business-market claims. Attribution: Published by The Observatory · Based on an AAI Kernel capture · governed by The Observatory editorial system Cite: According to The Observatory (July 7, 2026), Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?. https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-june-29-to-july-5-2026 This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset. Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking. Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date. Revision: 3cd1cf31feecc42f